Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
839.00    10.00 (1.21%)
Bid:
838.00
Ask:
840.00
Spread: 2.00 (0.239%)
Market Cap: £792.22m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

13 Apr 2026 07:00

RNS Number : 0699A
Polar Capital Holdings PLC
13 April 2026
 

13 April 2026 Polar Capital Holdings plc

AuM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides its regular quarterly update of its unaudited statement of Assets under Management ("AuM") for the financial year to 31 March 2026.

 

Group AuM (unaudited)

 

Polar Capital reports that as at 31 March 2026 its AuM was £30.6bn compared to £28.4bn at the end of December 2025, an increase of 8% over the quarter. In the quarter, AuM increased by net inflows of £1.4bn, fund performance and market movements of £0.8bn, offset by fund closures of £13m.

 

AuM movement in three months to 31 March 2026

Open ended

Funds

(£m)

Investment

Trusts

(£m)

Segregated mandates

(£m)

Total

(£m)

AuM at 1 January 2026

21,366

 

6,482

539

28,387

Net flows

 1,386

 (5)

62

1,443

Fund closures1

(13)

-

-

(13)

Market movement

and performance

685

128

3

816

Total AuM at 31 March 2026

23,424

6,605

604

30,633

 

 

 

AuM movement in twelve months to 31 March 2026

Open ended

Funds

(£m)

Investment

Trusts

(£m)

Segregated mandates

(£m)

Total

(£m)

AuM at 1 April 2025

15,994

4,846

569

21,409

Net flows

 1,233

 (237)

 (94)

 902

Corporate actions2

-

 (396)

-

(396)

Fund closures1

 (75)

-

-

 (75)

Market movement

and performance

 6,272

 2,392

 129

 8,793

Total AuM at 31 March 2026

23,424

6,605

604

30,633

1 Return of funds to investors upon the closure of the Polar Capital Emerging Market ex-China Stars Fund in February 2026, Polar Capital China Stars Fund in January 2026 and the Polar Capital Melchior European Opportunities Fund in November 2025.

2 Return of capital to investors in June 2025 as the Polar Capital Global Financials Trust underwent a 100% tender offer following which 44% of issued capital was tendered and in November 2025 when Polar Capital Global Healthcare Trust underwent a 100% tender offer following which 22% of issued capital was tendered.

 

 

Iain Evans, Chief Executive, commented:

"We have delivered a strong finish to the financial year, despite a backdrop of heightened geopolitical uncertainty and ongoing market volatility. Over the quarter, assets under management (AuM) increased by 8% to £30.6bn, up from £28.4bn at the end of December, supported by net inflows of £1.4bn.

 

"For the full financial year, AuM increased by 43% to £30.6bn, from £21.4bn at the end of March 2025, reflecting a combination of net inflows, fund performance and market movements. We delivered a second consecutive year of positive net inflows, totalling £902m (excluding corporate actions and fund closures), demonstrating the strength of our specialist investment capabilities.

 

"Flows during the quarter were broad-based, with several of our investment teams generating net inflows, led by Technology, Healthcare and Smart Energy. Net flows into our Global Technology (£722m) and Artificial Intelligence (£575m) funds remained particularly strong, driven by continued client interest in structural growth opportunities and supported by both increased allocations from existing clients and new client wins, notably across wealth and private bank channels in Europe and Asia.

 

"Our Healthcare strategies also contributed positively, including the launch of a new separately managed account in partnership with a Swiss wealth manager. In addition, Emerging Market Stars, Japan Value and Global Absolute Return funds each delivered net inflows, further highlighting the breadth of our platform.

 

"Net outflows were largely concentrated in North American (£97m), Global Insurance (£85m) and Asian Stars (£55m) funds, reflecting a small number of client-specific redemptions rather than any broader shift in demand or sentiment.

 

Outlook

"We have entered 2026 with positive net inflow momentum, although we remain mindful of the structural challenges facing the industry. Inflows were strongest in January and February, before moderating in March following the escalation of conflict in the Middle East. Encouragingly, positive momentum has continued into April to date.

"The geopolitical backdrop has become more uncertain, contributing to heightened market sensitivity, particularly in energy markets. Despite this, we remain confident in our positioning as a specialist boutique. As markets broaden and the pace of technological disruption, including AI, accelerates, the case for specialist active management is becoming increasingly compelling. Our focus on differentiated capabilities, deep expertise and disciplined execution positions us well to navigate the uncertainty and capture opportunities ahead for our clients and shareholders."

 

Polar Capital plans to announce its results for the financial year ended 31 March 2026 on 1 July 2026.

 

 

For further information please contact:

 

Polar Capital

Iain Evans (Chief Executive)

Samir Ayub (Chief Financial Officer)

 

+44 (0)20 7227 2700

 

Deutsche Numis - - Nomad and Joint Broker

Charles Farquhar

Duncan Monteith

Rajesh Iyer

 

+44 (0)20 7260 1000

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Thomas Philpott

 

+44 (0)20 3597 8680

 

 

Camarco - PR

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

+44 (0)20 3757 4980

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAKLEFDFKEFA
Date   Source Headline
30th Jun 20257:00 amRNSCEO Succession
27th Jun 202512:03 pmRNSForm 8.3 - Alpha Group International PLC
26th Jun 20253:10 pmRNSForm 8.3 - Alpha Group International PLC
23rd Jun 20257:00 amRNS-RInvestor Presentation covering Full Year Results
18th Jun 20256:07 pmRNSForm 8.3 - MITIE Group PLC
17th Jun 20252:56 pmRNSTotal Voting Rights
11th Jun 20256:12 pmRNSForm 8.3 - Mitie Group PLC
11th Jun 20254:36 pmRNSForm 8.3 - Mitie Group PLC
11th Jun 20254:32 pmRNSForm 8.3 - Mitie Group PLC
22nd May 202511:59 amRNSCrystallisation and Issue of Shares
15th May 20257:00 amRNSForm 8.3 - Alpha Group International PLC
8th May 202511:24 amRNSForm 8.3 - Alpha Group International PLC
7th May 20254:46 pmRNSForm 8.3 - Alpha Group International PLC
1st May 202510:59 amRNSDirector/PDMR Shareholding
23rd Apr 20255:13 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSAuM Update
9th Apr 20253:52 pmRNSHolding(s) in Company
8th Apr 20254:07 pmRNSDirector/PDMR Shareholding
7th Apr 20255:17 pmRNSHolding(s) in Company
26th Mar 20251:01 pmRNSHolding(s) in Company
25th Mar 20258:32 amRNSDirector/PDMR Shareholding
4th Mar 20259:44 amRNSHolding(s) in Company
3rd Feb 20253:34 pmRNSBlock listing Interim Review
28th Jan 20259:33 amRNSDirector/PDMR Shareholding
22nd Jan 20252:05 pmRNSHolding(s) in Company
22nd Jan 20251:44 pmRNSDirector/PDMR Shareholding
17th Jan 202511:07 amRNSDirector/PDMR Shareholding
16th Jan 20252:43 pmRNSForm 8.3 - Direct Line Insurance Group PLC
15th Jan 20252:24 pmRNSForm 8.3 - Direct Line Insurance Group PLC
14th Jan 20254:28 pmRNSForm 8.3 - Direct Line Group PLC
13th Jan 20257:00 amRNSAuM Update
24th Dec 202410:36 amRNSForm 8.3 - Direct Line Insurance Group PLC
23rd Dec 20245:11 pmRNSForm 8.3 - Intelligent Ultrasound Group PLC Amend
23rd Dec 202412:20 pmRNSForm 8.3 - Intelligent Ultrasound Group PLC
2nd Dec 202411:43 amRNSTotal Voting Rights
29th Nov 20244:54 pmRNSForm 8.3 - Direct Line Insurance Group PLC
26th Nov 202410:02 amRNSHolding(s) in Company
18th Nov 20247:00 amRNSUnaudited Interim Results
12th Nov 20249:14 amRNSCrystallisation of Business Unit & Issue of Shares
31st Oct 20247:00 amRNSNotice of Results
10th Oct 20247:00 amRNSAuM Update
26th Sep 20243:54 pmRNSReplacement: Result of AGM
25th Sep 20243:43 pmRNSResult of AGM
16th Aug 20242:08 pmRNSForm 8.3 - RENALYTIX PLC
15th Aug 202412:37 pmRNSForm 8.3 - RENALYTIX PLC
13th Aug 20243:08 pmRNSForm 8.3 - RENALYTIX PLC
5th Aug 20241:44 pmRNSBlock listing Interim Review
1st Aug 20249:16 amRNSDirector/PDMR Shareholding
22nd Jul 20244:53 pmRNSDirector/PDMR Shareholding
18th Jul 20244:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.